PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.
about
STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic InflammationPARP-14 binds specific DNA sequences to promote Th2 cell gene expression.Degradation of the transcription factors NF-κB, STAT3, and STAT5 is involved in Entamoeba histolytica-induced cell death in Caco-2 colonic epithelial cells.Increased DNA damage in progression of COPD: a response by poly(ADP-ribose) polymerase-1.Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell functionPoly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axisHigh salt primes a specific activation state of macrophages, M(Na)PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice.Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates T(H)2 differentiation and allergic airway disease.Therapeutic applications of PARP inhibitors: anticancer therapy and beyond8-Oxoguanine-DNA glycosylase 1 deficiency modifies allergic airway inflammation by regulating STAT6 and IL-4 in cells and in mice.Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactionsRole of poly(ADP-ribose) polymerases in the regulation of inflammatory processes.Update in clinical allergy and immunology.Beyond DNA repair, the immunological role of PARP-1 and its siblings.Mechanisms and potential therapeutic targets in allergic inflammation: recent insights.Silencing of poly(ADP-ribose) polymerase-1 suppresses hyperstretch-induced expression of inflammatory cytokines in vitro.Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review.PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice.Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response?Calpain-activated mTORC2/Akt pathway mediates airway smooth muscle remodelling in asthma.Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.PARP-1: a new player in the asthma field?Effects of PARP-1 deficiency on Th1 and Th2 cell differentiation.
P2860
Q26738332-A79C61AD-8F6E-40F5-A010-DF8746837FF5Q34039475-AE4885D9-46DD-4D81-A9A7-F43DE8C54ADEQ34411011-1A209613-701D-45CB-8459-F49556FC04CAQ34876209-FB26BB33-D87B-4FFD-9DAF-6A05CA4ED549Q35287136-5EBCBED6-7F5C-4943-AED4-BFDA5D5883B2Q35848889-C7CFC3CD-A993-4055-B629-4BC917A1510EQ35857399-392F7F8D-E553-4173-973D-1F2D1846FD56Q35925609-B46614DE-A072-4833-9A97-C22F361170A0Q36184688-B4532C5D-27EA-4237-8754-24BA63BA5E15Q36413076-93B404FE-C847-4AB5-83F4-22D15DC1F611Q36853236-6489CC50-89CE-4FB1-BD35-2685D9A22CAFQ37087958-897A0070-4500-43B3-B995-814C0855AB32Q37111145-8D67FFC0-B8C8-49D2-A31D-23C015773552Q38047690-93A889E9-ACE6-416F-995D-B82AEE059691Q38056516-07D71722-0CB9-4F0A-A518-AEF044A87F4DQ38089268-C66B14BC-F54A-4E20-BDCB-00875D5976D7Q38161574-DF5DAFCE-2D3F-4EA2-A65A-F0AAA096C66EQ38994860-15C6AB75-C292-4201-9B7C-A6D01D51BBE5Q41820940-8F6447F9-E82B-4292-9A7C-2430E34EBAFCQ45340890-7981F57C-B96D-4FA0-B1BE-6811F21B1111Q47767767-FA3E3DF8-05B8-4D15-BE01-5B4683ABC37FQ48040813-140A78A1-81E4-4EA1-ACE9-B5913F30B984Q52372449-B9B0E8D0-DEC4-45DE-BFF9-C30E8C5C3921Q53830448-CAB2D600-A500-43B5-B171-0F70E8349578Q54965132-E0899F0F-4029-43E5-AD34-DE53B41DF581
P2860
PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@ast
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@en
type
label
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@ast
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@en
prefLabel
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@ast
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@en
P2093
P2860
P1433
P1476
PARP-1 deficiency blocks IL-5 ...... AT-6 in a murine asthma model.
@en
P2093
A H Boulares
M Zerfaoui
V P Ronchi
P2860
P304
P356
10.1111/J.1398-9995.2011.02549.X
P577
2011-01-28T00:00:00Z